Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population

Molecular Biology Reports

Volumn 41, Issue 2, 2014, Pages 799-807

  Jaiswal, Praveen Kumar ^a   Singh, Vibha ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

BCG; Bladder cancer risk; CTLA4; Haplotype; RFLP

Indexed keywords

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CTLA-4 ANTIGEN; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 84899433156     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2919-2     Document Type: Article

References (42)

1. Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH (2010) The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 105:300-308
2. Sinha R, Anderson DE, McDonald SS, Greenwald P (2003) Cancer risk and diet in India. J Postgrad Med 49:222-228 (Pubitemid 37493414)
3. Rahimifar S, Erfani N, Sarraf Z, Ghaderi A (2010) ctla-4 gene variations may influence cervical cancer susceptibility. Gynecol Oncol 119:136-139
4. Kimkong I, Nakkuntod J, Sae-Ngow S, Snabboon T, Avihingsanon Y, Hirankarn N (2011) Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves' disease in Thai population. Asian Pac J Allergy Immunol 29:229-235
5. Torres B, Aguilar F, Franco E, Sánchez E, Sánchez- Román J, Jiménez Alonso J, Núñez- Roldán A, Martín J, González-Escribano MF (2004) Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Arthritis Rheum 50:2211-2215 (Pubitemid 38924399)
6. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165:6606-6611
7. Daroszewski J, Pawlak E, Karabon L, Frydecka I, Jonkisz A, Slowik M, Bolanowski M (2009) Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms. Eur J Endocrinol 161:787-793
8. Valk E, Rudd CE, Schneider H (2008) CTLA-4 trafficking and surface expression. Trends Immunol 29:272-279
9. Suwalska K, Pawlak E, Karabon L, Tomkiewicz A, Dobosz T, Urbaniak-Kujda D, Kuliczkowski K, Wolowiec D, Jedynak A, Frydecka I (2008) Association studies of CTLA-CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population. Hum Immunol 69:193-201
10. Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Pezeshki AM, Doroudchi M, Dehaghani AS (2004) Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat 86:1-7 (Pubitemid 38918893)
11. Monne M, Piras G, Palmas A, Arru L, Murineddu M, Latte G, Noli A, Gabbas A (2004) Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma. Am J Hematol 76:14-18 (Pubitemid 38579532)
12. Zheng C, Huang D, Liu L, Björkholm M, Holm G, Yi Q, Sundblad A (2001) Cytotoxic T-lymphocyte antigen-4 microsatellite polymorphism is associated with multiple myeloma. Br J Haematol 112:216-218 (Pubitemid 32151174)
13. Colombel M, Soloway M, Akaza H (2008) Epidemiology, staging, grading, and risk stratification of bladder cancer. Eur Urol Suppl 7:618-626
14. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
15. Bava KA, Gromiha MM, Uedaira H, Kitajima K, Sarai A (2004) ProTherm, version 4.0: thermodynamic database for proteins and mutants. Nucleic Acids Res 32:D120-D121 (Pubitemid 38081618)
16. Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR (2006) An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet 15:2490-2508 (Pubitemid 44288702)
17. Goren A, Ram O, Amit M, Keren H, Lev-Maor G, Vig I, Pupko T, Ast G (2006) Comparative analysis identifies exonic splicing regulatory sequences - the complex definition of enhancers and silencers. Mol Cell 22:769-781
18. Zhang XH, Kangsamaksin T, Chao MS, Banerjee JK, Chasin LA (2005) Exon inclusion is dependent on predictable exonic splicing enhancers. Mol Cell Biol 25:7323-7332 (Pubitemid 41105927)
19. Garg A, Kaur H, Raghava GP (2005) Real value prediction of solvent accessibility in proteins using multiple sequence alignment and secondary structure information. Proteins 61:318-324 (Pubitemid 41429139)
20. Yutaka A, Kentaro O, Tamotsu N, Makoto A (1998) Parallel protein information analysis (PAPIA) system running on a 64-node PC cluster. In: Proceedings of the 9th genome informatics workshop (GIW'98). Universal Academy Press, pp 131-140
21. Ahirwar DK, Agrahari A, Mandhani A, Mittal RD (2009) Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy. Biomarkers 14:213-218
22. Ahirwar D, Mandhani A, Mittal RD (2009) Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer. Arch Med Res 40:97-102
23. Ahirwar DK, Mandhani A, Mittal RD (2010) IL-8-251 T>A polymorphism is associated with bladder cancer susceptibility and outcome after BCG immunotherapy in a northern Indian cohort. Arch Med Res 41:97-103
24. Gangwar R, Ahirwar D, Mandhani A, Mittal RD (2009) Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in North India. Urology 73:675-680
25. Gangwar R, Ahirwar D, Mandhani A, Mittal RD (2009) Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population? Mutat Res 680:56-63
26. Gangwar R, Mandhani A, Mittal RD (2011) Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India. Surgery 149:126-134
27. Mittal RD, Gangwar R, Mandal RK, Srivastava P, Ahirwar DK (2012) Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer. Mol Biol Rep 39:1667-1675
28. Mayans S, Lackovic K, Nyholm C, Lindgren P, Ruikka K, Eliasson M, Cilio CM, Holmberg D (2007) CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in Northern Sweden. BMC Med Genet 8:3
29. Gough SC, Walker LS, Sansom DM (2005) CTLA4 gene polymorphism and autoimmunity. Immunol Rev 204:102-115 (Pubitemid 40460496)
30. Su TH, Chang TY, Lee YJ, Chen CK, Liu HF, Chu CC, Lin M, Wang PT, Huang WC, Chen TC, Yang YC (2007) CTLA-4 gene and susceptibility to human papillomavirus-16- associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis 28:1237-1240 (Pubitemid 47062682)
31. Wong YK, Chang KW, Cheng CY, Liu CJ (2006) Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma. J Oral Pathol Med 35:51-54
32. Hu L, Liu J, Chen X, Zhang Y, Liu L, Zhu J, Chen J, Shen H, Qiang F, Hu Z (2010) CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers-hepatocellular carcinoma and cervical cancer. Hum Immunol 71:888-891
33. Solerio E, Tappero G, Iannace L, Matullo G, Ayoubi M, Parziale A, Cicilano M, Sansoè Framarin L, Vineis P, Rosina F (2005) CTLA4 gene polymorphism in Italian patients with colorectal adenoma and cancer. Dig Liver Dis 37:170-175 (Pubitemid 41070535)
34. Wang W, Wang J, Song H, Liu J, Song B, Cao X (2011) Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism is associated with increased risk of osteosarcoma. Genet Test Mol Biomarkers 15:503-506
35. Lang C, Chen L, Li S (2012) Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism and susceptibility to pancreatic cancer. DNA Cell Biol 31:683-687
36. Cozar JM, Romero JM, Aptsiauri N, Vazquez F, Vilchez JR, Tallada M, Garrido F, Ruiz-Cabello F (2007) High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Hum Immunol 68:698-704 (Pubitemid 47126657)
37. Qi P, Ruan CP, Wang H, Zhou FG, Xu XY, Gu X, Zhao YP, Dou TH, Gao CF (2010) CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese. Int J Colorectal Dis 25:39-45
38. Liu Y, Liang WB, Gao LB, Pan XM, Chen TY, Wang YY, Xue H, Zhang LS, Zhang L (2010) CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease. Hum Immunol 71:1141-1146
39. Wang L, Li D, Fu Z, Li H, Jiang W, Li D (2007) Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. BMC Cancer 7:173
40. Palacios R, Comas D, Elorza J, Villoslada P (2008) Genomic regulation of CTLA4 and multiple sclerosis. J Neuroimmunol 203:108-115
41. Pincerati MR, Dalla-Costa R, Petzl-Erler ML (2010) CTLA4CT60 gene polymorphism is not associated with differential susceptibility to pemphigus foliaceus. Genet Mol Biol 33:442-444
42. Azarpira N, Malekhosseini SA, Aghdaie MH, Daraie M (2010) CTLA4 CT60 A/G gene polymorphism in liver transplant recipients. Exp Clin Transplant 8:210-213